bioRxivPhysiology
Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response
M. Keefe, H. Soderholm, H.-Y. Shih, T. Stevenson, K. Glaittli, D. M. Bowles, E. Scholl, S. Colby, S. Merchant, E. Hsu, J. Bonkowsky
Abstract
Vanishing White Matter disease (VWM) is a severe leukodystrophy of the central nervous system caused by mutations in subunits of the eukaryotic initiation factor 2B complex (eIF2B). Current models only partially recapitulate key disease features, and pathophysiology is poorly understood. Through development and validation of zebrafish (Danio rerio) models of VWM, we demonstrate that zebrafish eif2b mutants phenocopy VWM, including impaired somatic growth, early lethality, impaired myelination, loss of oligodendrocyte precursor cells, increased apoptosis in the CNS, and impaired motor swimming behavior. Expression of human EIF2B2 in the zebrafish eif2b2 mutant rescues lethality and CNS apoptosis, demonstrating conservation of function between zebrafish and human. In the mutants, intron 12 retention leads to expression of a truncated eif2b5 transcript. Expression of the truncated eif2b5 in wild-type larva impairs motor behavior and activates the ISR, suggesting that a feed-forward mechanism in VWM is a significant component of disease pathophysiology.
- organism: zebrafish
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gene supplementation in Vanishing White Matter mice ameliorates the disease
Anne E.J. Hillen, Robbert Zalm, … Vivi Majella Heine·bioRxiv·Dec 9, 2025
- eIF2B Activator Rescues Neonatal Lethality of an eIF2Bα Sugar Phosphate Binding Mutation Associated with Vanishing White Matter Disease
Karin Lin, Nina Ly, … Carmela Sidrauski·JCI InsightPeer-reviewed·Jul 15, 2025
- Integrated Stress Response Deregulation underlies Vanishing White Matter and is a target for therapy
Truus E. M. Abbink, Lisanne E. Wisse, … Marjo S. van der Knaap·bioRxiv·Dec 4, 2018
- eIF2B activator prevents neurological defects caused by a chronic Integrated Stress Response
Yao Liang Wong, Lauren LeBon, … Carmela Sidrauski·eLifePeer-reviewed·Jan 9, 2019
- The Translational Landscape of Reactive Astrocytes Reveals the Impact of eIF2B-mediated Dysregulation in VWM Disease
Shir Mandelboum, Liat Lev-Ari, … Orna Elroy‐Stein·NAR Molecular MedicinePeer-reviewed·Mar 24, 2025
- Identification of repurposable cytoprotective drugs for Vanishing White Matter Disease
Neville S. Ng, Mauricio Castro Cabral-da-Silva, … Lezanne Ooi·Translational Medicine CommunicationsPeer-reviewed·Oct 21, 2020